Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Pembrolizumab-Associated Hypoparathyroidism: A Single Case Report.
Journal: AACE clinical case reports
Published: March 15, 2021
Effects of concomitant combination of SGLT-2 inhibitor and GLP-1 receptor agonist on renal outcomes in T2D with eGFR below 30 and macroalbuminuria: A case series.
Journal: Clinical case reports
Published: November 25, 2020
Liraglutide treatment in overweight and obese patients with type 1 diabetes: A 26-week randomized controlled trial; mechanisms of weight loss.
Journal: Diabetes, obesity & metabolism
Published: February 12, 2020
Testosterone Increases the Expression and Phosphorylation of AMP Kinase α in Men With Hypogonadism and Type 2 Diabetes.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 03, 2019
Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes.
Journal: Diabetes, obesity & metabolism
Published: September 18, 2018
Effect of Testosterone on FGF2, MRF4, and Myostatin in Hypogonadotropic Hypogonadism: Relevance to Muscle Growth.
Journal: The Journal of clinical endocrinology and metabolism
Published: September 07, 2018
VISUAL VIGNETTE.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: August 15, 2018
Exenatide Increases IL-1RA Concentration and Induces Nrf-2‒Keap-1‒Regulated Antioxidant Enzymes: Relevance to β-Cell Function.
Journal: The Journal of clinical endocrinology and metabolism
Published: October 25, 2017
Diminished androgen and estrogen receptors and aromatase levels in hypogonadal diabetic men: reversal with testosterone.
Journal: European journal of endocrinology
Published: August 16, 2017
Liraglutide acutely suppresses glucagon, lipolysis and ketogenesis in type 1 diabetes.
Journal: Diabetes, obesity & metabolism
Published: January 13, 2017
Ezetimibe and simvastatin combination inhibits and reverses the pro-inflammatory and pro-atherogenic effects of cream in obese patients.
Journal: Atherosclerosis
Published: December 09, 2016
Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 05, 2016
Last Updated: 09/26/2026